Patent directory · USPTO A61K / A61P
Patents matching “Maximus Diagnostic Technologies LLC”
3 pharma patents match "Maximus Diagnostic Technologies LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3 pharmaceutical patents matching "Maximus Diagnostic Technologies LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12379385
Methods of treating patients afflicted with irritable bowel syndrome, inflammatory bowel disease or chronic gastrointestinal functional disorders based on assessment of intestinal barrier function
granted -
US 11693015
Methods of treating patients afflicted with irritable bowel syndrome, inflammatory bowel disease or chronic gastrointestinal functional disorders based on assessment of intestinal barrier function
granted -
US 10663473
Method of identifying a status of a mucosal intestinal epithelial barrier to improve treatment of inflammatory bowel disease
granted